David HumesDirector of Product Development, InvoltaLatest in HomeSponsoredMusk Says Neuralink Will Begin ‘High-Volume’ Production of Brain ImplantsApril 9, 2026Micro-bladder Model Offers Clues to Stopping Recurrent UTIsSeptember 4, 2026Boston Scientific Spinal Implant Recall Linked to Over 1,000 InjuriesSeptember 4, 2026Mindray Opens Expanded Warehouse Facility in New JerseySeptember 3, 2026Related StoriesHomeThe Consequences of Quality FailsHomeFixing Four Critical Supply Chain FlawsHomeMarijuana-Dependent Patients at Higher Risk for Infection After Surgical ProceduresSponsor ContentMusk Says Neuralink Will Begin ‘High-Volume’ Production of Brain Implants
